Botulinum Toxin Serotype A on the Treatment of Hypertrophic Burn Scars in Pediatric Age: Case Report
DOI:
https://doi.org/10.25759/spmfr.304Keywords:
Botulinum Toxins, Type A/therapeutic use, Burns, Child, Cicatrix, HypertrophicAbstract
Botulinum toxin application on post burn hypertrophic scars has had a growing international interest. Despite this, up to this day, there are no scientific publications or case reports in Portugal on the usual data bases. We present the first case published in Portugal, as well as the protocol in use and the objective and patient-reported results. The positive results achieved are in line with the existing literature. This technique should thus be considered in selected patients, constituting an added value in the rehabilitation of hyperthrophic scars sequelae.
Downloads
References
Ohgi S, Gu S. Pediatric burn rehabilitation: Philosophy and strategies. Burns Trauma. 2013; 1 :73-9. doi: 10.4103/2321-3868.118930.
Mari W , Alsabri SG, Simman R. Novel Insights on Understanding of Keloid Scar. J Am Coll Clin Wound Spec. 2015; 7: 1–7.
Arno AI, Gauglitz GG, Jeschke MG, Review Up-to-date approach to manage keloids and hypertrophic scars: A useful guide. Burns. 2014; 40: 1255–66.
European Medicines Agency. [consultado em 23.11.2017] Disponível em: http://www.ema.europa.eu/docs/en_GB/document_library/Referrals_document/Botox_29/WC500010942.pdf.
Amaro J, Moreira J, Aguiar Branco C. Medicina Física e de Reabilitação: A Especialidade Médica. Rev Soc Port Med Fís Reabil. 2009; 18:
Gassner HG, Sherris DA, Otley CC. Treatment of facial wounds with botulinum toxin A improves cosmetic outcome in primates Plast Reconstr Surg . 2000;105:1948-53; discussion 1954-5. doi: 10.1097/00006534-200005000-00005.
Xiao Z, Qu G. Effects of botulinum toxin type A on collagen deposition in hypertrophic scars. Molecules. 2012; 17: 2169-77.
Austin E, Koo E, Jagdeo J. The cellular response of keloids and hypertrophic scars to botulinum toxin A: a comprehensive literature review. Dermatol Surg. 2018;44:149-57.
Kim YS, Lee HJ, Cho SH, Lee JD, Kim HS. Early postoperative treatment of thyroidectomy scars using botulinum toxin: A split-scar, double-blind randomized controlled trial; Wound Repair Regen. 2014;22:605-12.
Zhang DZ, Liu XY, Xiao WL, Xu YX. Botulinum toxin type A and the prevention of hypertrophic scars on the maxillofacial area and neck: a metaanalysis of randomized controlled trials. PLoS One. 2016;11:e0151627.
Batifol D, de Boutray M, Galmiche S, Finiels PJ, Jammet P. Treatment of Keloid Scars by Botulinum Toxin. J Ear Nose Throat Disord. 2017;2: 1024.
Prodromidou A, Frountzas M,Pergialiotis V. Botulinum toxin for the prevention and healing of wound scars: A systematic review of the literature. Plast Surg. 2015;23:260-4. doi: 10.4172/plastic-surgery.1000934.
Xiao Z, Zhang F, Cui Z. Treatment of hypertrophic scars with intralesional botulinum toxin type A injections: a preliminary report. Aesth Plast Surg. 2009; 33:409–12.
Lauretti GR, Rosa C.P, Kitayama A, Lopes B. Comparison of Botox® or Prosigne® and Facial Nerve Blockade as Adjuvant in Chronic Migraine. J Biomed Sci Eng.2014; 7: 446-52.
Downloads
Published
How to Cite
Issue
Section
License
Copyright statement
Authors must also submit a copyright statement (as seen below) on article submission.
To the Editor-in-chief of the SPMFR Journal:
The below signed author(s) hereby state that the article
________________________________________ (ref. MFR_________) is
an original unpublished work and all facts stated are a product of the author(s) investigation. This article does not violate any copyright laws or privacy statements. The author(s) also hereby confirm that there is no conflict of interest's issues in this article.
By submitting this article the author(s) agree that after publication all copyrights belong to the SPMFR Journal.
Signed by all authors
Date:
Names (capital letters):
Signatures:
The SPMFR Journal’s contents are follow a Creative Commons licence. After publication the authors can hand out the articles as long as the SPMFR Journal is credited.
